Oligometastatic Disease Clinical Trials
0 recruiting
Showing 1–6 of 6 trials
Recruiting
Not Applicable
MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
Radiotherapy Side EffectProstate CancerOligometastatic Disease+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT05183074
Recruiting
Phase 3
Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC
Oligometastatic DiseaseMetastatic Non Small Cell Lung Cancer
Tata Memorial Hospital190 enrolled1 locationNCT05278052
Recruiting
Phase 2
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
Non-small Cell Lung CancerOligometastatic DiseaseDriver Mutation
Tata Memorial Hospital106 enrolled1 locationNCT05277844
Recruiting
Phase 2
High-Risk Metachronous Oligometastatic Prostate Cancer Trial
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore88 enrolled1 locationNCT06212583
Recruiting
Phase 3
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Prostate CancerMetastatic CancerProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven873 enrolled1 locationNCT05352178
Recruiting
Not Applicable
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
Breast Cancer Stage IVOligometastatic Disease
Vastra Gotaland Region345 enrolled1 locationNCT05377047